← back to search

Juliane Hörner‐Rieber

German Cancer Research Center · DE
Area of research
Pulmonary and Respiratory Medicine · Otorhinolaryngology
Research interest
Research interests include Lung Cancer Diagnosis and Treatment, Head and Neck Cancer Studies, Advanced Radiotherapy Techniques, and Cancer-related molecular mechanisms research.
h-index
26
citations
2,441
works
288
NIH funding
primary concept
email

Recent publications

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025
Breast Care 2025cited by 14position: middledoi
MR-linac: role of artificial intelligence and automation
Strahlentherapie und Onkologie 2025cited by 11position: middledoi
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2025
Breast Care 2025cited by 4position: middledoi
Prospective planning comparison of magnetic resonance-guided vs. internal target volume-based stereotactic body radiotherapy of hepatic metastases – Which patients do really benefit from an MR-linac?
Clinical and Translational Radiation Oncology 2025cited by 2position: lastdoi
Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profiles
Neuro-Oncology 2025cited by 2position: middledoi
Deep learning-based contour propagation in magnetic resonance imaging-guided radiotherapy of lung cancer patients
Physics in Medicine and Biology 2025cited by 2position: middledoi
Partial Breast Reirradiation for Breast Cancer Recurrences After Repeat Breast-Conserving Surgery with Proton Beam Therapy: The Prospective BREAST Trial (NCT06954623)
Journal of Clinical Medicine 2025cited by 1position: middledoi
Incidence and Risk Assessment of Capsular Contracture in Breast Cancer Patients following Post-Mastectomy Radiotherapy and Implant-Based Reconstruction
Cancers 2024cited by 21position: lastdoi
Clinical Workflow of Cone Beam Computer Tomography-Based Daily Online Adaptive Radiotherapy with Offline Magnetic Resonance Guidance: The Modular Adaptive Radiotherapy System (MARS)
Cancers 2024cited by 11position: middledoi
Bone Marrow Sparing by Intensity Modulated Proton Beam Therapy in Postoperative Irradiation of Gynecologic Malignancies
Technology in Cancer Research & Treatment 2024cited by 10position: middledoi
Daily AI-Based Treatment Adaptation under Weekly Offline MR Guidance in Chemoradiotherapy for Cervical Cancer 1: The AIM-C1 Trial
Journal of Clinical Medicine 2024cited by 10position: lastdoi
Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer
Frontiers in Oncology 2024cited by 10position: lastdoi
Impact of daily plan adaptation on accumulated doses in ultra-hypofractionated magnetic resonance-guided radiation therapy of prostate cancer
Physics and Imaging in Radiation Oncology 2024cited by 9position: middledoi
Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial
JHEP Reports 2024cited by 7position: middledoi
Intrafraction organ movement in adaptive MR-guided radiotherapy of abdominal lesions – dosimetric impact and how to detect its extent in advance
Radiation Oncology 2024cited by 7position: middledoi
Exploring Helium Ions’ Potential for Post-Mastectomy Left-Sided Breast Cancer Radiotherapy
Cancers 2024cited by 7position: middledoi
Radiation-Induced Cerebral Contrast Enhancements Strongly Share Ischemic Stroke Risk Factors
International Journal of Radiation Oncology*Biology*Physics 2024cited by 6position: middledoi
Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases – Clinical outcome and prognostic factors
Clinical and Translational Radiation Oncology 2024cited by 6position: middledoi
Validation of different automated segmentation models for target volume contouring in postoperative radiotherapy for breast cancer and regional nodal irradiation
Clinical and Translational Radiation Oncology 2024cited by 6position: lastdoi
Efficacy and toxicity of photon, proton, and carbon ion radiotherapy in the treatment of intracranial solitary fibrous tumor/hemangiopericytoma
Radiation Oncology 2024cited by 5position: middledoi
Hematologic Toxicity Profiles and the Impact of Hemoglobin Nadir and Transfusion on Oncologic Outcome in Definitive Radiochemotherapy for Cervical Cancer
Cancers 2024cited by 5position: lastdoi
Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer – Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial
Clinical and Translational Radiation Oncology 2024cited by 4position: middledoi
Efficacy of palliative hemostatic radiotherapy for tumor bleeding and pain relief in locally advanced pelvic gynecological malignancies
Strahlentherapie und Onkologie 2024cited by 4position: lastdoi
MR-linac based radiation therapy in gastrointestinal cancers: a narrative review
Journal of Gastrointestinal Oncology 2024cited by 2position: middledoi
Compliance of volunteers in a fully-enclosed patient rotation system for MR-guided radiation therapy: a prospective study
Radiation Oncology 2024cited by 2position: middledoi
Clinical Outcomes of Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Adrenal Metastases from a Single Institution
Cancers 2024cited by 2position: lastdoi
How to protect the proximal bronchial tree during stereotactic radiotherapy of ultracentral lung tumors: Lessons from MR-guided treatment
Clinical and Translational Radiation Oncology 2024cited by 2position: lastdoi
Analysis of safety and efficacy of proton radiotherapy for optic nerve sheath meningioma
Neuro-Oncology Advances 2024cited by 1position: middledoi
Fractionated stereotactic radiotherapy of brainstem metastases – Clinical outcome and prognostic factors
Clinical and Translational Radiation Oncology 2024cited by 1position: middledoi
Metastasis-directed stereotactic radiotherapy in patients with breast cancer: results of an international multicenter cohort study
Clinical & Experimental Metastasis 2024cited by 1position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jürgen Debus · NYU Langone Health91 papers (2017–2025)Laila König · Heidelberg University61 papers (2017–2025)Fabian Weykamp · German Cancer Research Center39 papers (2020–2025)Sebastian Regnery · Brigham and Women's Hospital38 papers (2020–2025)Eva Meixner · DKFZ-ZMBH Alliance32 papers (2021–2025)Sebastian Klüter · Heidelberg University31 papers (2020–2025)Philipp Hoegen · German Cancer Research Center27 papers (2019–2024)Tanja Eichkorn · Heidelberg University26 papers (2020–2025)Sebastian Adeberg · Goethe University Frankfurt22 papers (2017–2023)Kristin Lang · Heidelberg University22 papers (2019–2024)Carolin Buchele · University Hospital Heidelberg21 papers (2020–2025)Carolin Rippke · University Hospital Heidelberg21 papers (2020–2024)C. Katharina Renkamp · DKFZ-ZMBH Alliance20 papers (2020–2025)Klaus Herfarth · Universitätsklinik für Strahlentherapie20 papers (2019–2025)Semi Harrabi · Heidelberg University19 papers (2017–2025)Jonathan W. Lischalk · New York University19 papers (2020–2025)Tobias Förster · Ludwig-Maximilians-Universität München17 papers (2019–2024)Nathalie Arians · Heidelberg University17 papers (2019–2024)Philipp Hoegen-Saßmannshausen · German Cancer Research Center16 papers (2023–2025)Thomas Held · Heidelberg University16 papers (2020–2025)